Infectious Diseases - Over half of long COVID patients suffer persistent cognitive slowing, new study reveals
Can't see this email? View it online
   
  Infectious Diseases  
  The latest infectious diseases news from News Medical  
 

Core reagents for vaccine efficacy evaluationCore reagents for vaccine efficacy evaluation

Immunogenicity is a critical part of evaluating vaccine efficacy. Explore ACRO's antigen-specific antibodies and ELISA kits to help evaluate immunogenicity for your vaccine research throughout various diseases including RSV, VZV, RABV, influenza virus, and much more.

Explore the Features of Core Reagents
 
   Over half of long COVID patients suffer persistent cognitive slowing, new study revealsOver half of long COVID patients suffer persistent cognitive slowing, new study reveals
 
Study finds that 53% of long COVID patients experience significant cognitive slowing, a symptom that does not improve over time and is independent of the severity of the initial SARS-CoV-2 infection.
 
   Do yellow fever vaccines truly provide effective lifelong protection against the disease after a single dose?Do yellow fever vaccines truly provide effective lifelong protection against the disease after a single dose?
 
The long-term protection offered by one dose of vaccine against yellow fever.
 
 Effects of varying COVID-19 vaccination rates on population-level health outcomes across variant waves in the U.S.
 
Effects of varying COVID-19 vaccination rates on population-level health outcomes across variant waves in the U.S.Effects of varying COVID-19 vaccination rates on population-level health outcomes across variant waves in the U.S.
 
 
 UKHSA unveils groundbreaking Pathogen Genomics Strategy for pandemic preparedness
 
UKHSA unveils groundbreaking Pathogen Genomics Strategy for pandemic preparednessThe UK Health Security Agency (UKHSA) has today published its Pathogen Genomics Strategy, laying out a 5 year plan for the organization's role in the wider delivery of pathogen genomics to prepare for and respond to infectious disease threats to public health.
 
 
 Evidence from Malawi: Typhoid conjugate vaccine provides protection for up to four years
 
Evidence from Malawi: Typhoid conjugate vaccine provides protection for up to four yearsStudy shows that a single dose of typhoid conjugate vaccine provides over four years of protection against typhoid fever in Malawian children, proving effective across all age groups.
 
 
 New drug combination could reduce malaria infection risk in pregnant women living with HIV
 
New drug combination could reduce malaria infection risk in pregnant women living with HIVResearchers have tested a new combination of medications that could thwart resistance to common malaria drugs, significantly reducing the infection risk in pregnant women living with HIV.
 
 
    MediKnowledge - Your new AI assistant for trusted Medical Knowledge - is now live in the GPT Store.MediKnowledge - Your new AI assistant for trusted Medical Knowledge - is now live in the GPT Store.
 

Use this GPT to search for edited and trustworthy references, articles, and equipment reviews from over 20 years of trusted medical and healthcare content.

Currently only available to ChatGPT Plus account holders.

 
Ask a Question Now
 
 
 

How would you rate today's newsletter?